Physician profile
Sheetal Kale
NPI 1073648549
$8,591.11
in general payments reported to CMS, 2019-2025
40 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $401 · 2021: $652 · 2022: $5,575 · 2023: $655 · 2024: $394 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $4,939.99 | 2022-2023 | |
| Abbvie INC. | $505.87 | 2019-2025 | |
| Hologic Sales and Service, LLC | $331.28 | 2020-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Myosure Tissue Removal Device |
| Myovant Sciences INC. | $262.43 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $239.95 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $226.29 | 2021-2024 | |
| Evofem Biosciences, INC. | $204.47 | 2020-2022 | |
| Organon LLC | $202.70 | 2021-2024 | |
| Minerva Surgical, INC | $193.54 | 2019 | |
| Therapeuticsmd, INC. | $163.83 | 2019-2021 | |
| Channel Medsystems, INC. | $143.03 | 2021-2022 | |
| Medtronic USA, INC. | $126.77 | 2019 | |
| Millicent US INC | $86.92 | 2020-2024 | Intrarosa, Femring |
| Exeltis, USA INC. | $75.45 | 2019-2024 | Slynd |
| Astellas Pharma US INC | $72.50 | 2023-2025 | Veozah |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $72.43 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Agile Therapeutics, INC. | $64.90 | 2021-2023 | Twirla |
| Currax Pharmaceuticals LLC | $59.47 | 2021-2025 | Contrave |
| Daiichi Sankyo INC. | $58.70 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.99 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $48.83 | 2020-2022 | |
| Coopersurgical, INC. | $48.46 | 2020-2022 | |
| Shield Therapeutics INC | $44.38 | 2024 | |
| Boston Scientific Corporation | $41.65 | 2019-2024 | |
| Amgen INC. | $36.96 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $30.26 | 2019 | |
| Duchesnay USA Incorporated | $26.95 | 2019 | |
| Allergan, INC. | $24.48 | 2019 | |
| Novo Nordisk INC | $23.79 | 2022 | |
| Aspira Women'S Health INC | $20.99 | 2024 | Ova1 |
| Medline Industries Lp | $20.43 | 2025 | |
| Optumhealth Care Solutions, LLC | $17.85 | 2023 | Vivify Health Care Team Portal |
| Vertical Pharmaceuticals, LLC | $17.19 | 2019 | |
| Baxter Healthcare | $17.16 | 2023 | Floseal |
| Pacira Pharmaceuticals Incorporated | $15.82 | 2022 | |
| Biogen, INC. | $15.12 | 2025 | Zurzuvae |
| Lilly USA, LLC | $15.09 | 2025 | Zepbound |
| Lupin INC. | $14.67 | 2020 | |
| Covidien Lp | $14.10 | 2019 | |
| Avion Pharmaceuticals | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheetal Kale listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.